Skip to main content
. 2021 Feb 8;2021:6635704. doi: 10.1155/2021/6635704

Table 1.

Clinical characteristics in the initially detected and false-negative EGCs.

Initially detected EGCs (n = 100) False-negative EGCs (n = 119) P value
Age (years) 71 [61–79] 72 [63–79] 0.61
Men 73 (73.0%) 86 (72.3%) 0.90
Previous ESD/EMR 1 (1.0%) 34 (28.6%) <0.01
Symptomatic 30 (30.0%) 12 (10.1%) <0.01
Atrophic gastritis 0.38
 Opened type 87 (87.0%) 108 (90.8%)
 None or closed type 13 (13.0%) 11 (9.2%)
Helicobacter pylori status <0.01
 Currently infected 75 (75.0%) 50 (42.0%)
 Past infected 18 (18.0%) 64 (53.8%)
 Uninfected 7 (7.0%) 5 (4.2%)
Endoscopist 0.59
 Experienced 69 (69.0%) 86 (72.3%)
 Trainee 31 (31.0%) 33 (27.7%)
Purpose <0.01
 Screening 78 (78.0%) 43 (36.1%)
 Surveillance 1 (1.0%) 37 (31.1%)
 Annual medical checkup 21 (21.0%) 39 (32.8%)
Tumor size (mm) 15 [9–23] 9 [5–13] <0.01
Depth 0.09
 M 90 (90.0%) 115 (96.6%)
 sm1 2 (2.0%) 0 (0%)
 sm2 or deeper 8 (8.0%) 4 (3.4%)
Pathological differentiation 0.19
 Well or moderate 83 (83.0%) 106 (89.1%)
 Poorly 17 (17.0%) 13 (10.9%)
Location 0.82
 Upper 13 (13.0%) 19 (16.0%)
 Middle 33 (33.0%) 37 (31.1%)
 Lower 54 (54.0%) 63 (52.9%)
Circumference 0.51
 Anterior wall 23 (23.0%) 22 (18.5%)
 Posterior wall 25 (25.0%) 40 (33.6%)
 Lesser curvature 35 (35.0%) 36 (30.3%)
 Greater curvature 17 (17.0%) 21 (17.7%)
Color <0.01
 Reddish 55 (55.0%) 71 (59.7%)
 Discolored 40 (40.0%) 29 (24.4%)
 Normal 5 (5.0%) 19 (16.0%)
Tumor morphology 0.33
 Elevated 33 (33.0%) 29 (24.4%)
 Flat 9 (9.0%) 11 (9.2%)
 Depressed 57 (58.0%) 79 (66.4%)
Erosion 0.86
 Present 45 (45.0%) 55 (46.2%)
 Absent 55 (55.0%) 64 (53.8%)
Gastritis-like appearance <0.01
 Present 15 (15.0%) 42 (35.3%)
 Absent 85 (85.0%) 77 (64.7%)
Spontaneous bleeding 0.72
 Present 16 (16.0%) 17 (14.3%)
 Absent 84 (84.0%) 102 (85.7%)

Data are presented as median (IQR) or n (%). EGC: early gastric cancer; ESD: endoscopic submucosal dissection; EMR: endoscopic mucosal resection.